On March 27, 2023 Acorda Therapeutics, Inc. (Nasdaq: ACOR) reported that it will hold a virtual, video Q&A with its CEO, Ron Cohen, M.D., on Tuesday, April 4 at 1:00pm ET, 10:00am PT (Press release, Acorda Therapeutics, MAR 27, 2023, View Source [SID1234629354]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Dr. Cohen will present an overview of the Company and review its 2022 financial and business performance. Participants will be able to submit questions to Dr. Cohen, which he will address live.
Video Q&A Participation Instructions
To participate in the video event:
Click the link below from a laptop or mobile device. (Mobile device users will be prompted to download the BlueJeans app.)
View Source
If prompted, enter the following case-sensitive Event ID: yewueufw
To participate over the phone:
Dial 1-800-520-9950 (US: Toll Free)
Enter Meeting ID: 1224536
Smartphone users can click on the following link to automatically be connected:
800-520-9950,,,1224536#
To submit a question:
Prior to the Q&A, questions can be emailed to [email protected].
During the live Q&A, questions can be typed into the BlueJeans chat window.